These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 1311894

  • 1. Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
    Takeda R, Yamazaki T, Ito Y, Koshida H, Morise T, Miyamori I, Hashimoto T, Morimoto S.
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):186-90. PubMed ID: 1311894
    [Abstract] [Full Text] [Related]

  • 2. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
    Sundsfjord JA, Marton P, Jorgensen H, Aakvaag A.
    J Clin Endocrinol Metab; 1974 Oct; 39(4):734-9. PubMed ID: 4370321
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aldosterone: review of its physiology and diagnostic aspects of primary aldosteronism.
    Horton R.
    Metabolism; 1973 Dec; 22(12):1525-45. PubMed ID: 4357694
    [No Abstract] [Full Text] [Related]

  • 5. Primary aldosteronism.
    McGuffin WL, Gunnells JC.
    Urol Clin North Am; 1977 Jun; 4(2):227-37. PubMed ID: 331615
    [No Abstract] [Full Text] [Related]

  • 6. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
    Biglieri EG, Kater CE, Arteaga EE.
    J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
    [Abstract] [Full Text] [Related]

  • 7. Functional black adenoma of the adrenal cortex. A rare cause of primary aldosteronism.
    Caplan RH, Virata RL.
    Am J Clin Pathol; 1974 Jul; 62(1):97-103. PubMed ID: 4134750
    [No Abstract] [Full Text] [Related]

  • 8. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
    Ganguly A, Luetscher JA, Weinberger MH.
    Clin Exp Hypertens A; 1982 Jul; 4(9-10):1695-714. PubMed ID: 6291813
    [Abstract] [Full Text] [Related]

  • 9. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K, Gregorová I, Tomsová Z, Vancura J, Silinková-Málková E.
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract] [Full Text] [Related]

  • 10. [Primay hyperaldosteronism--diagnostic and treatment].
    Potthoff SA, Beuschlein F, Vonend O.
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2480-4. PubMed ID: 23168980
    [Abstract] [Full Text] [Related]

  • 11. Aldosterone-producing adenoma with prolonged amelioration by dexamethasone.
    Gomi Y, Taniyama M, Ban Y, Takahashi R, Suzuki S, Murai M.
    Endocr J; 2001 Jun; 48(3):331-6. PubMed ID: 11523904
    [Abstract] [Full Text] [Related]

  • 12. [A description of a case of Conn's syndrome (author's transl)].
    Martin PL, Dallocchio M, Fourcade JP, Clémenty J, Coqueran J, Choussat A, Bricaud H.
    J Radiol Electrol Med Nucl; 1974 May; 55(5):419-22. PubMed ID: 4408421
    [No Abstract] [Full Text] [Related]

  • 13. [An observation of Conn's syndrome. Clinical and biological study].
    Tourniaire J, Revol A, Maret G, Blanc-Brunat N.
    Rev Fr Endocrinol Clin; 1968 May; 9(4):333-50. PubMed ID: 4302797
    [No Abstract] [Full Text] [Related]

  • 14. Rhabdomyolysis due to primary hyperaldosteronism.
    Martínez JJ, Oliveira CL, Meneses AL, Rodríguez SA, Corrales PP, López AH, Romero FB.
    Endocrinol Nutr; 2009 Oct; 56(8):431-4. PubMed ID: 19959155
    [Abstract] [Full Text] [Related]

  • 15. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
    Vetter H, Vetter W.
    Klin Wochenschr; 1975 Apr 15; 53(8):391-3. PubMed ID: 211313
    [Abstract] [Full Text] [Related]

  • 16. Favorable surgical outcomes of aldosterone-producing adenoma based on lateralization by CT imaging and hypokalemia: a non-AVS-based strategy.
    Li H, Liu J, Feng X, Liu L, Wei G, Cao X, Li Y.
    Int Urol Nephrol; 2017 Dec 15; 49(12):2151-2156. PubMed ID: 28918446
    [Abstract] [Full Text] [Related]

  • 17. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
    Sakamoto H, Ichikawa S, Sakamaki T, Nakamura T, Ono Z, Takayama Y, Murata K.
    Am J Hypertens; 1990 Jul 15; 3(7):533-7. PubMed ID: 2194510
    [Abstract] [Full Text] [Related]

  • 18. An additional child case of an aldosterone-producing adenoma with an atypical presentation of peripheral paralysis due to hypokalemia.
    Dinleyici EC, Dogruel N, Acikalin MF, Tokar B, Oztelcan B, Ilhan H.
    J Endocrinol Invest; 2007 Nov 15; 30(10):870-2. PubMed ID: 18075291
    [Abstract] [Full Text] [Related]

  • 19. [Endocrinologic and circulatory findings in a case of primary aldosteronism].
    Marsen B, Dissmann T, Oelkers W, Lohmann FW, Molzahn M, Gotzen R.
    Dtsch Med Wochenschr; 1971 May 28; 96(22):951-4. PubMed ID: 5578596
    [No Abstract] [Full Text] [Related]

  • 20. Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism.
    Hennings J, Andreasson S, Botling J, Hägg A, Sundin A, Hellman P.
    Langenbecks Arch Surg; 2010 Feb 28; 395(2):133-7. PubMed ID: 19418066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.